Effects of cannabis use on human behavior, including cognition, motivation, and psychosis: a review

ND Volkow, JM Swanson, AE Evins, LE DeLisi… - JAMA …, 2016 - jamanetwork.com
With a political debate about the potential risks and benefits of cannabis use as a backdrop,
the wave of legalization and liberalization initiatives continues to spread. Four states …

The role of the posterior cingulate cortex in cognition and disease

R Leech, DJ Sharp - Brain, 2014 - academic.oup.com
The posterior cingulate cortex is a highly connected and metabolically active brain region.
Recent studies suggest it has an important cognitive role, although there is no consensus …

A systematic review of the antipsychotic properties of cannabidiol in humans

TA Iseger, MG Bossong - Schizophrenia research, 2015 - Elsevier
Despite extensive study over the past decades, available treatments for schizophrenia are
only modestly effective and cause serious metabolic and neurological side effects …

Cannabinoid receptors: An update on cell signaling, pathophysiological roles and therapeutic opportunities in neurological, cardiovascular, and inflammatory …

D Haspula, MA Clark - International journal of molecular sciences, 2020 - mdpi.com
The identification of the human cannabinoid receptors and their roles in health and disease,
has been one of the most significant biochemical and pharmacological advancements to …

Endocannabinoid system components as potential biomarkers in psychiatry

F Navarrete, MS García-Gutiérrez… - Frontiers in …, 2020 - frontiersin.org
The high heterogeneity of psychiatric disorders leads to a lack of diagnostic precision.
Therefore, the search of biomarkers is a fundamental aspect in psychiatry to reach a more …

Cannabis and adolescent brain development

DI Lubman, A Cheetham, M Yücel - Pharmacology & therapeutics, 2015 - Elsevier
Heavy cannabis use has been frequently associated with increased rates of mental illness
and cognitive impairment, particularly amongst adolescent users. However, the …

Consensus paper of the WFSBP task force on cannabis, cannabinoids and psychosis

DC D'Souza, M DiForti, S Ganesh… - The World Journal of …, 2022 - Taylor & Francis
Objectives The liberalisation of cannabis laws, the increasing availability and potency of
cannabis has renewed concern about the risk of psychosis with cannabis. Methods The …

Cannabidiol as a potential treatment for psychosis

C Davies, S Bhattacharyya - Therapeutic advances in …, 2019 - journals.sagepub.com
Psychotic disorders such as schizophrenia are heterogeneous and often debilitating
conditions that contribute substantially to the global burden of disease. The introduction of …

Effect of bitopertin, a glycine reuptake inhibitor, on negative symptoms of schizophrenia: a randomized, double-blind, proof-of-concept study

D Umbricht, D Alberati, M Martin-Facklam… - JAMA …, 2014 - jamanetwork.com
Importance In schizophrenia, the severity of negative symptoms is a key predictor of long-
term disability. Deficient signaling through theN-methyl-D-aspartate receptor is hypothesized …

[HTML][HTML] Nonopioid placebo analgesia is mediated by CB1 cannabinoid receptors

F Benedetti, M Amanzio, R Rosato, C Blanchard - Nature medicine, 2011 - nature.com
Placebo analgesia is mediated by both opioid and nonopioid mechanisms, but so far
nothing is known about the nonopioid component. Here we show that the specific CB1 …